Brief: Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million
BRIEF-Roivant Sciences Q1 Adjusted Net Income USD -290.606 Million Vs. IBES Estimate USD -192.3 Million Aug 06 (Reuters) - Roivant Sciences Q1 revenue USD 1.442 million.
- Q1 net income USD -290.606 million
- Q1 pretax profit USD -294.564 million vs. IBES estimate USD -243.7 million
- Q1 basic EPS USD -0.26
- Q1 income from operations USD -365.993 million vs. IBES estimate USD -306.8 million
- Q1 operating expenses USD 367.827 million
Recent news on Roivant Sciences
See all newsU.S. STOCKS ON THE MOVE-Thermo Fisher, CME, Capital One, Northern Trust
Roivant rises as drug succeeds in two late-stage trials for eye disease
Immunovant falls after lupus drug setback
Brief: Roivant Announces Topline Results From Proof-Of-Concept Study Of Imvt-1402 In Cutaneous Lupus Erythematosus
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple